Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs). [electronic resource]
Publication details: Stem cells international 2019Description: 6961052 p. digitalISSN:- 1687-966X
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.